5.1
Strong Sell
Sentiment
-1.00
Impact
0.50
Momentum
-0.04
Fundamentals
+0.00
Volume
1.00

IMP

Dược phẩm Imexpharm

Dược phẩm Y tế 📰 1 新闻 →
56
-0.18%
Market Cap: 1.5T

新闻情绪

已分析文章
3
主要情绪
Negative
Negative 2
Neutral 1

最新新闻

Apr 10, 2026

The Ministry of Health has issued a directive to ensure a stable, timely, and reasonably priced supply of essential drugs, urging provinces, hospitals, and pharmaceutical companies to prevent shortages, hoarding, and unreasonable price increases while prioritizing domestic production.

↗ 外部来源
7 Neutral

Multiple executives at Imexpharm sell shares citing personal financial adjustments; other transactions include Diamond Properties reducing NVL holdings, OCB insider sales, and foreign fund buying SHS shares.

↗ 外部来源
6 Negative

Imexpharm (IMP) executives, including CEO Trần Thị Đào, registered to sell 607,400 shares (0.44% stake) from mid-April to mid-May 2026 for personal financial planning. The planned sales coincide with the company's annual meeting on April 22 and ambitious 2026 targets of VND 3,200B revenue (+9.8%) and VND 502B pre-tax profit (+12.6%).

insider trade Aveluro 研究
4 Negative

相关股票 — Dược phẩm

DBD — Dược - Trang thiết bị y tế Bình Định DCL — Dược phẩm Cửu Long DHG — Dược Hậu Giang DMC — Xuất nhập khẩu Y tế Domesco LDP — Dược Lâm Đồng - Ladophar MED — Dược Trung ương Mediplantex TRA — Traphaco

股票分析

Dược phẩm sector 最新新闻 仪表盘

所有信息仅供参考，不构成投资建议。过往表现不代表未来收益。数据来源于越南公开市场信息。

最后更新: 2026-04-19T13:59:46Z.